News | Institut Curie

équipe vagner

RNA and cancer: the translation process influenced by multiple factors09/27/2021

Couvertures RA

Annual Report 2020 – Working together to beat cancer09/22/2021

Détection du tissu d'origine chez les patients atteints de cancers d’origine inconnue grâce à l’IA

Institut Curie is developing an artificial intelligence tool for diagnosing cancer of un-known primary08/16/2021

Publi Théry

Distinguishing between vesicles to better understand tumor progression08/09/2021

Centre de Recherche Institut Curie

FHL3: A Scaffold Protein, Architect of the Embryonic Nervous System07/30/2021

COMPASS

Pediatric cancers

Pediatric Cancer: Identifying New Therapies with the European COMPASS Project07/13/2021

Chunlong Chen

A next-generation method for examining DNA replication using “single molecule” analysis 07/13/2021

Mondrian

Institut Curie launches the first study to assess the clinical utility of circulating tumor DNA in the evaluation of chemotherapy response07/13/2021

Neuroblastome

Pediatric cancers

High-risk neuroblastoma: targeted therapy could be used in first line treatment06/14/2021

ASCO 2021 IC

Nanomedicine and new targeted therapies: the advances of Institut Curie at the ASCO 2021 Meeting06/14/2021